Embecta Corp. (NASDAQ:EMBC) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On May 23, Mizuho lowered the firm’s price target on Embecta Corp. (NASDAQ:EMBC) to $13 from $15, keeping a Neutral rating on the shares. The rating came after analyst day, with the firm telling investors in a research note that the company’s long-term guidance calls for sales to stay relatively flat through 2028.
An assembly line of medical devices being packed for distribution.
Following similar circumstances, Travis Steed from Bank of America Securities maintained a Sell rating on Embecta Corp. in a report released on May 28, setting a price target of $18.00.
Embecta Corp. provides medical devices used to treat diabetes. The company’s offerings include syringes, pen needles, and safety devices fitted with a digital application.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
This article is originally published at Insider Monkey.
